Bickerstaffe R, Brock P, Husson J-M, Rubin I, Bragman K, Paterson K, Sommerville A
Ethical Issues Committee, Faculty of Pharmaceutical Medicine, London, UK.
Int J Clin Pract. 2006 Feb;60(2):242-52. doi: 10.1111/j.1742-1241.2006.00804.x.
The practice of pharmaceutical medicine brings with it ethical challenges and dilemmas often very different from those encountered in the practice of clinical medicine. Having established a framework of guiding ethical principles, this report aims to look in some detail at specific areas of possible ethical concern to pharmaceutical physicians, offering practical advice and guidance on good practice. The report covers issues related to pharmaceutical research, including dissemination of research findings, communication with other health professionals and patients and involvement of pharmaceutical physicians and companies in the provision of patient services. The primacy of the interests of patients and the wider public is emphasised, and the possible impact of new developments in pharmaceutical technology is explored. It is hoped that the report will help those working in pharmaceutical medicine and act as a stimulus for wider discussion and debate.
药学医学实践带来了伦理挑战和困境,这些挑战和困境往往与临床医学实践中遇到的截然不同。在确立了指导伦理原则的框架后,本报告旨在详细探讨药学医师可能关注的特定伦理领域,就良好实践提供实用建议和指导。该报告涵盖与药物研究相关的问题,包括研究结果的传播、与其他医疗专业人员和患者的沟通,以及药学医师和公司在提供患者服务方面的参与。强调了患者和更广泛公众利益的首要性,并探讨了制药技术新发展可能产生的影响。希望本报告能帮助从事药学医学工作的人员,并成为更广泛讨论和辩论的推动力。